SEARCH

SEARCH BY CITATION

References

  • Alving A, Craige B, Pullman T, Whorton CM, Jones R & Eichelberger L (1948) Procedures used at Stateville penitentiary for the testing of potential antimalarial agents. The Journal of Clinical Investigation 27, 25.
  • Armed Forces Epidemiological Board (AFEB) (2002) February 19, 2002 Meeting Minutes, San Diego, California. Available at: http://www.health.mil/dhb/afeb/meeting/Transcripts/Day1Transcripts.pdf (accessed 21 June 2012).
  • Barnett ED (2004) Infectious disease screening for refugees resettled in the United States. Clinical Infectious Diseases 39, 833841.
  • Bawden MP, Slaten DD & Malone JD (1995) Falciparum malaria in a displaced Haitian population. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 600603.
  • Björkman A (1989) Acute psychosis following mefloquine prophylaxis. Lancet 2, 865.
  • Burgoine KL, Bancone G & Nosten F (2010) The reality of using primaquine. Malaria Journal 9, 376.
  • Castot A & Garnier R (1988) [Consideration of the side effects of mefloquine: a medico-surgical consultation]. Le Concours Médical 198, 4003.
  • Centers for Disease Control and Prevention (CDC) (2010) Presumptive treatment of P. falciparum malaria in refugees relocating from sub-Saharan Africa to the United States. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/malaria-guidelines-domestic.html (accessed 21 June 2012).
  • Clyde DF, McCarthy VC, Miller RM & Hornick RB (1976) Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrobial Agents and Chemotherapy 9, 384386.
  • de Souza JM (1983) A phase I clinical trial of mefloquine in Brazilian male subjects. Bulletin of the World Health Organization 61, 809814.
  • Denbeaux M, Camoni S, Beroth B et al. (2010) Drug abuse: an exploration of the government’s use of mefloquine at Guantanamo. Available at: http://law.shu.edu/ProgramsCenters/PublicIntGovServ/policyresearch/upload/drug-abuse-exploration-government-use-mefloquine-gunatanamo.pdf (accessed 21 June 2012).
  • Department of Defense (DoD) (2007) Detainee Hospital Guantanamo Bay Cuba Standard Operating Procedures (SOPs), Operational Policy Memorandums concerning health care, Behavioral Science Consultation Team (BSCT) SOPs. Available at: http://www.dod.mil/pubs/foi/operation_and_plans/Detainee/GITMO_MedicalSOPs.pdf (accessed 21 June 2012).
  • Department of the Army Office of the Surgeon General. (2002) Memorandum: updated health care provider information on use of mefloquine hydrochloride (Lariam®) for malaria prophylaxis. Available at: http://www.pdhealth.mil/downloads/Mefloquine_Hyrochloride_Use.pdf (accessed 21 June 2012).
  • Dow GS, Hudson TH, Vahey M & Koenig ML (2003) The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malaria Journal 2, 14.
  • Dow G, Bauman R, Caridha D et al. (2006) Mefloquine induces dose-related neurological effects in a rat model. Antimicrobial Agents and Chemotherapeutics 50, 10451053.
  • Fernex M (1981) [Urgent need to develop new antimalarials]. Schweizerische Rundschau für Medizin Praxis 70, 10251032.
  • Furlow B (2011) US physician whistleblowers face intimidation and retaliation. Lancet Oncology 12, 727.
  • Greenwood BM (2004) The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas. The American Journal of Tropical Medicine and Hygiene 70, 17.
  • Greenwood BM (2010) Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas. Malaria Journal 9(3 Suppl), S2.
  • Gutiérrez LA, Naranjo NJ, Cienfuegos AV et al. (2009) Population structure analyses and demographic history of the malaria vector Anopheles albimanus from the Caribbean and the Pacific regions of Colombia. Malaria Journal 19, 259.
  • Hall AP, Doberstyn EB, Karnchanachetanee C et al. (1977) Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. British Medical Journal 1, 16261628.
  • Harinasuta T, Bunnag D & Wernsdorfer WH (1983) A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bulletin of the World Health Organization 61, 299305.
  • Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET & Magill AJ (2006) Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. American Journal of Tropical Medicine and Hygiene 75, 402415.
  • Hood JE, Jenkins JW, Milatovic D, Rongzhu L & Aschner M (2010) Mefloquine induces oxidative stress and neurodegeneration in primary rat cortical neurons. Neurotoxicology 31, 518523.
  • Iacopino V & Xenakis SN (2011) Neglect of medical evidence of torture in Guantánamo bay: a case series. PLoS Medicine 8, e1001027.
  • Karbwang J, Na Bangchange K, Thanavibul A, Back DJ & Bunnag D (1992) Pharmacokinetics of mefloquine in the presence of primaquine. European Journal of Clinical Pharmacology 42, 559560.
  • Kaye J & Leopold J (2011) KBR’s foreign contractors at Guantanamo spared controversial anti-malaria drug given to detainees. Available at: http://www.truth-out.org/contractors-treatment-undercuts-pentagon-rationale-giving-guantanamodetainees-anti-malarial-drug681 (accessed 21 June 2012).
  • Kofi Ekue JM, Ulrich AM, Rwabwogo-Atenyi J & Sheth UK (1983) A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. Bulletin of the World Health Organization 61, 713718.
  • Lapras J, Vighetto A, Trillet M & Garin JP (1989) [Transient disorders of memory after a malaria attack. Caused by mefloquine?]. Presse Médicale 18, 776.
  • LaRocque RC, Rao SR, Lee J et al. (2011) Global TravEpiNet: a national consortium of clinics providing care to international travelers–analysis of demographic characteristics, travel destinations, and pretravel healthcare of high-risk US international travelers, 2009–2011. Clinical Infectious Diseases 54, 455462.
  • Leopold J & Kaye J (2010) Controversial Drug Given to All Guantanamo Detainees Akin to ‘Pharmacologic Waterboarding’. Available at: http://www.truth-out.org/controversial-drug-given-all-guantanamo-detainees-amounted-pharmacologic-waterboarding6558 (accessed 21 June 2012).
  • Magill AJ (2006) Malaria: diagnosis and treatment of falciparum malaria in travelers during and after travel. Current Infectious Disease Reports 8, 3542.
  • Magill AJ, Cersovsky SB & DeFraites RF (2011) CDC Health Information for International Travel 2012. Advising travelers with specific needs: special considerations for US military deployments. Available at: wwwnc.cdc.gov/travel/yellowbook/2012/chapter-8-advising-travelers-with-specific-needs/special-considerations-for-us-military-deployments.htm (accessed 21 June 2012).
  • Matisz CE, Naidu P, Shokoples SE et al. (2011) Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. The American Journal of Tropical Medicine and Hygiene 84, 161165.
  • Maugh TH (1977) Malaria drugs: new ones are available, but little used. Science 196, 415.
  • Miller JM, Boyd HA, Ostrowski SR et al. (2000) Malaria, intestinal parasites, and schistosomiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. The American Journal of Tropical Medicine and Hygiene 62, 115121.
  • Milner E, McCalmont W, Bhonsle J et al. (2010) Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols. Malaria Journal 9, 51.
  • Molina-Cruz A, de Mérida A, Mills K et al. (2004) Gene flow among Anopheles albimanus populations in Central America, South America, and the Caribbean assessed by microsatellites and mitochondrial DNA. The American Journal of Tropical Medicine and Hygiene 71, 350359.
  • Nevin RL (2010) Mefloquine prescriptions in the presence of contraindications: prevalence among US military personnel deployed to Afghanistan, 2007. Pharmacoepidemiology and Drug Safety 19, 206210.
  • Nevin RL (2012) Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report. Travel Medicine and Infectious Disease 10, 144151.
  • Nevin RL, Pietrusiak PP & Caci JB (2008) Prevalence of contraindications to mefloquine use among USA military personnel deployed to Afghanistan. Malaria Journal 7, 30.
  • Nosten F, McGready R, Looareesuwan S & White NJ (2003) Editorial: maternal malaria: time for action. Tropical Medicine and International Health 8, 485487.
  • Office of the Assistant Secretary of Defense for Health Affairs (OASDHA) (2009) Policy Memorandum on the Use of Mefloquine (Lariam®) in Malaria Prophylaxis. Available at: http://www.health.mil/libraries/HA_Policies_and_Guidelines/09-017.pdf (accessed 21 June 2012).
  • Office of the Assistant Secretary of Defense for Health Affairs (OASDHA) (2012) Memorandum dated 17 January 2012, Subject: Service Review of Mefloquine Prescribing Practices. Available at: truth-out.org/files/Mefloquine-QA-Memo-JAN-2012-(Signed).pdf (accessed 21 June 2012).
  • Oliver M, Simon F, de Monbrison F et al. (2008) [New use of primaquine for malaria]. Médecine et maladies infectieuses 38, 169179.
  • Overbosch D, Schilthuis H, Bienzle U et al. (2001) Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clinical Infectious Diseases 33, 10151021.
  • Parikh R, Amole I, Tarpley M, Gbadero D, Davidson M & Vermund SH (2010) Cost comparison of microscopy vs. empiric treatment for malaria in southwestern Nigeria: a prospective study. Malaria Journal 9, 371.
  • Patchen LC, Campbell CC & Williams SB (1989) Neurologic reactions after a therapeutic dose of mefloquine. New England Journal of Medicine 321, 14151416.
  • Pearlman EJ, Doberstyn EB, Sudsok S, Thiemanun W, Kennedy RS & Canfield CJ (1980) Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). American Journal of Tropical Medicine and Hygiene 29, 11311137.
  • Phares CR, Kapella BK, Doney AC et al. (2011) Presumptive treatment to reduce imported malaria among refugees from east Africa resettling in the United States. The American Journal of Tropical Medicine and Hygiene 85, 612615.
  • Price R, Nosten F, Simpson JA et al. (1999) Risk factors for gametocyte carriage in uncomplicated falciparum malaria. The American Journal of Tropical Medicine and Hygiene 60, 10191023.
  • Rendi-Wagner P, Noedl H, Wernsdorfer WH, Wiedermann G, Mikolasek A & Kollaritsch H (2002) Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults. Acta Tropica 81, 167173.
  • Rouveix B, Bricaire F, Michon C et al. (1989) Mefloquine and an acute brain syndrome. Annals of Internal Medicine 110, 577578.
  • Scheinkman A, Williams M, McLean A, Ashkenas J & Tse A (2012) The Guantánamo docket: a history of the detainee population. Available at http://projects.nytimes.com/guantanamo (accessed 21 June 2012).
  • Scsepko MM (2002) West Nile virus: next stop GTMO? The Wire: Published in the interest of personnel assigned to JTF-160 and COM-NAV Base Guantanamo Bay, Cuba, 30 August, 10–11. Available at: http://upload.wikimedia.org/wikipedia/commons/1/19/The_Wire_Issue12v2.pdf (accessed 21 June 2012).
  • Shane L (2011) Experts: DOD malaria drug policy for detainees is malpractice. Available at: http://www.stripes.com/experts-dod-malaria-drug-policy-for-detainees-is-malpractice-1.132623 (accessed 21 June 2012).
  • Sirima SB, Cotte AH, Konaté A et al. (2006) Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. The American Journal of Tropical Medicine and Hygiene 75, 205211.
  • Slutsker L, Tipple M, Keane V, McCance C & Campbell CC (1995) Malaria in east African refugees resettling to the United States: development of strategies to reduce the risk of imported malaria. The Journal of Infectious Diseases 171, 489493.
  • Stauffer WM, Weinberg M, Newman RD et al. (2008) Pre-departure and post-arrival management of P. falciparum malaria in refugees relocating from sub-Saharan Africa to the United States. The American Journal of Tropical Medicine and Hygiene 79, 141146.
  • Strauch S, Jantratid E, Dressman JB et al. (2011) Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride. Journal of Pharmceutical Sciences 100, 1121.
  • Tagbor H, Bruce J, Agbo M, Greenwood B & Chandramohan D (2010) Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS ONE 5, e14425.
  • Tin F, Hlaing N & Lasserre R (1982) Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Bulletin of the World Health Organization 60, 913917.
  • Toovey S (2009) Mefloquine neurotoxicity: a literature review. Travel Medicine and Infectious Disease 7, 26.
  • Trenholme CM, Williams RL, Desjardins RE et al. (1975) Mefloquine (WR 142,490) in the treatment of human malaria. Science 190, 792794.
  • United Nations Development Programme (UNDP), World Bank & World Health Organization (1983) Development of mefloquine as an antimalarial drug. Bulletin of the World Health Organization 61, 169178.
  • von Seidlein L & Greenwood BM (2003) Mass administrations of antimalarial drugs. Trends in Parasitology 19, 452460.
  • Wallace MR, Sharp TW, Smoak B et al. (1996) Malaria among United States troops in Somalia. American Journal of Medicine 100, 4955.
  • White NJ (2005) Intermittent presumptive treatment for malaria. PLoS Medicine 2, e3.
  • Whitman TJ, Coyne PE, Magill AJ et al. (2010) An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. The American Journal of Tropical Medicine and Hygiene 83, 258265.
  • World Health Organization (WHO) (1989) Central nervous system reactions related to the antimalarial drug, mefloquine, WHO/MAL/89/1054. Available at: http://whqlibdoc.who.int/malaria/WHO_MAL_89.1054.pdf (accessed 21 June 2012).
  • World Health Organization (WHO) (2001) The use of antimalarial drugs: report of an informal consultation, 13–17 November 2000. Available at: http://whqlibdoc.who.int/hq/2001/WHO_CDS_RBM_2001.33.pdf (accessed 21 June 2012).
  • World Health Organization (WHO) (2004) A strategic framework for malaria prevention and control during pregnancy in the African Region. Available at: http://whqlibdoc.who.int/afro/2004/AFR_MAL_04.01.pdf (accessed 21 June 2012).
  • World Health Organization (WHO) (2010) Guidelines for the Treatment of Malaria, 2nd edn. Available at: http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf (accessed 21 June 2012).